Eric Warren - 07 Mar 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
07 Mar 2023
Transactions value $
-$25,730
Form type
4
Filing time
08 Mar 2023, 15:22:06 UTC
Previous filing
19 Oct 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$25.7K -5.09K -9.49% $5.06* 48.6K 07 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.